100 related articles for article (PubMed ID: 16037233)
1. Effect of glucose concentration on formation of AGEs in erythrocytes in vitro.
Nagai R; Deemer EK; Brock JW; Thorpe SR; Baynes JW
Ann N Y Acad Sci; 2005 Jun; 1043():146-50. PubMed ID: 16037233
[TBL] [Abstract][Full Text] [Related]
2. Effect of inhibitor compounds on Nε-(carboxymethyl)lysine (CML) and Nε-(carboxyethyl)lysine (CEL) formation in model foods.
Srey C; Hull GL; Connolly L; Elliott CT; del Castillo MD; Ames JM
J Agric Food Chem; 2010 Nov; 58(22):12036-41. PubMed ID: 21043504
[TBL] [Abstract][Full Text] [Related]
3. Conventional antibody against Nepsilon-(carboxymethyl)lysine (CML) shows cross-reaction to Nepsilon-(carboxyethyl)lysine (CEL): immunochemical quantification of CML with a specific antibody.
Koito W; Araki T; Horiuchi S; Nagai R
J Biochem; 2004 Dec; 136(6):831-7. PubMed ID: 15671494
[TBL] [Abstract][Full Text] [Related]
4. Usefulness of antibodies for evaluating the biological significance of AGEs.
Nagai R; Fujiwara Y; Mera K; Motomura K; Iwao Y; Tsurushima K; Nagai M; Takeo K; Yoshitomi M; Otagiri M; Ikeda T
Ann N Y Acad Sci; 2008 Apr; 1126():38-41. PubMed ID: 18079488
[TBL] [Abstract][Full Text] [Related]
5. Immunochemical detection of Nepsilon-(carboxyethyl)lysine using a specific antibody.
Nagai R; Fujiwara Y; Mera K; Yamagata K; Sakashita N; Takeya M
J Immunol Methods; 2008 Mar; 332(1-2):112-20. PubMed ID: 18242632
[TBL] [Abstract][Full Text] [Related]
6. Membrane proteins of human erythrocytes are modified by advanced glycation end products during aging in the circulation.
Ando K; Beppu M; Kikugawa K; Nagai R; Horiuchi S
Biochem Biophys Res Commun; 1999 Apr; 258(1):123-7. PubMed ID: 10222246
[TBL] [Abstract][Full Text] [Related]
7. Formation of N(epsilon)-(carboxymethyl)lysine and loss of lysine in casein glucose-fatty acid model systems.
Lima M; Assar SH; Ames JM
J Agric Food Chem; 2010 Feb; 58(3):1954-8. PubMed ID: 20030411
[TBL] [Abstract][Full Text] [Related]
8. Glutaraldehyde is an effective cross-linker for production of antibodies against advanced glycation end-products.
Mera K; Nagai M; Brock JW; Fujiwara Y; Murata T; Maruyama T; Baynes JW; Otagiri M; Nagai R
J Immunol Methods; 2008 May; 334(1-2):82-90. PubMed ID: 18353354
[TBL] [Abstract][Full Text] [Related]
9. Investigation of pathways of advanced glycation end-products accumulation in macrophages.
Nagai R; Fujiwara Y; Mera K; Otagiri M
Mol Nutr Food Res; 2007 Apr; 51(4):462-7. PubMed ID: 17390398
[TBL] [Abstract][Full Text] [Related]
10. S-(2-Succinyl)cysteine: a novel chemical modification of tissue proteins by a Krebs cycle intermediate.
Alderson NL; Wang Y; Blatnik M; Frizzell N; Walla MD; Lyons TJ; Alt N; Carson JA; Nagai R; Thorpe SR; Baynes JW
Arch Biochem Biophys; 2006 Jun; 450(1):1-8. PubMed ID: 16624247
[TBL] [Abstract][Full Text] [Related]
11. Chemical modification of muscle protein in diabetes.
Alt N; Carson JA; Alderson NL; Wang Y; Nagai R; Henle T; Thorpe SR; Baynes JW
Arch Biochem Biophys; 2004 May; 425(2):200-6. PubMed ID: 15111128
[TBL] [Abstract][Full Text] [Related]
12. Renoprotective and lipid-lowering effects of LR compounds, novel advanced glycation end product inhibitors, in streptozotocin-induced diabetic rats.
Figarola JL; Scott S; Loera S; Xi B; Synold T; Rahbar S
Ann N Y Acad Sci; 2005 Jun; 1043():767-76. PubMed ID: 16037304
[TBL] [Abstract][Full Text] [Related]
13. Rapid and simple method for determination of Nepsilon-(carboxymethyl)lysine and Nepsilon-(carboxyethyl)lysine in urine using gas chromatography/mass spectrometry.
Petrovic R; Futas J; Chandoga J; Jakus V
Biomed Chromatogr; 2005 Nov; 19(9):649-54. PubMed ID: 15803449
[TBL] [Abstract][Full Text] [Related]
14. Advanced glycation end product free adducts are cleared by dialysis.
Agalou S; Ahmed N; Thornalley PJ; Dawnay A
Ann N Y Acad Sci; 2005 Jun; 1043():734-9. PubMed ID: 16037300
[TBL] [Abstract][Full Text] [Related]
15. High-dose thiamine therapy counters dyslipidemia and advanced glycation of plasma protein in streptozotocin-induced diabetic rats.
Karachalias N; Babaei-Jadidi R; Kupich C; Ahmed N; Thornalley PJ
Ann N Y Acad Sci; 2005 Jun; 1043():777-83. PubMed ID: 16037305
[TBL] [Abstract][Full Text] [Related]
16. Analysis of protein glycation products by MALDI-TOF/MS.
Kislinger T; Humeny A; Peich CC; Becker CM; Pischetsrieder M
Ann N Y Acad Sci; 2005 Jun; 1043():249-59. PubMed ID: 16037245
[TBL] [Abstract][Full Text] [Related]
17. The effect of packed red blood cell storage on arachidonic acid and advanced glycation end-product formation.
Lysenko L; Mierzchała M; Gamian A; Durek G; Kübler A; Kozłowski R; Sliwiński M
Arch Immunol Ther Exp (Warsz); 2006; 54(5):357-62. PubMed ID: 17031463
[TBL] [Abstract][Full Text] [Related]
18. Quantification of N-(glucitol)ethanolamine and N-(carboxymethyl)serine: two products of nonenzymatic modification of aminophospholipids formed in vivo.
Fountain WC; Requena JR; Jenkins AJ; Lyons TJ; Smyth B; Baynes JW; Thorpe SR
Anal Biochem; 1999 Jul; 272(1):48-55. PubMed ID: 10405292
[TBL] [Abstract][Full Text] [Related]
19. Site specificity of glycation and carboxymethylation of bovine serum albumin by fructose.
Hinton DJ; Ames JM
Amino Acids; 2006 Jun; 30(4):425-34. PubMed ID: 16583308
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and characterization of styrene oxide adducts with cysteine, histidine, and lysine in human globin.
Jágr M; Mráz J; Linhart I; Stránský V; Pospísil M
Chem Res Toxicol; 2007 Oct; 20(10):1442-52. PubMed ID: 17867648
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
